Cardiac Assist Devices Market is Expected to Witness Robust Growth by 2032, Estimates DelveInsight
DelveInsight’s “Cardiac Assist Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report delivers an in-depth understanding of the market dynamics, competitive landscape, key growth drivers, emerging technologies, and future opportunities shaping the global cardiac assist devices industry.
Interested to know which cardiac assist device segments will capture the highest market share?
Download the report to understand the latest cardiac assist devices market trends and forecasts – https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr
Key Takeaways from the Cardiac Assist Devices Market Report
-
The global Cardiac Assist Devices market was valued at USD 2.89 billion in 2024 and is projected to reach USD 6.23 billion by 2032, growing at a CAGR of 13.70% during the forecast period.
-
Rising prevalence of cardiovascular diseases, including heart failure, coronary artery disease, and related conditions, is significantly increasing demand for cardiac assist devices as life-saving support systems.
-
Growing scarcity of donor hearts and longer transplant waiting times are accelerating adoption of cardiac assist devices as critical bridge and destination therapy solutions.
-
Technological advancements in device design – including smaller implantable LVADs, percutaneous pumps, AI-enabled systems, and improved materials – are enhancing usability, durability, and patient comfort.
-
Left Ventricular Assist Devices (LVADs) are expected to hold a significant share of the market, driven by their pivotal role in managing severe heart failure and widespread clinical adoption.
-
North America is expected to account for the highest proportion of the cardiac assist devices market, supported by high cardiovascular disease prevalence, organ donor shortages, and strong regulatory and infrastructure backing.
-
Increasing product launches, regulatory approvals, strategic collaborations, and R&D investments are strengthening market expansion globally.
-
The Europe cardiac assist devices market, Asia-Pacific cardiac assist devices market, and Rest of the World cardiac assist devices market are expected to create significant future growth opportunities.
-
Leading cardiac assist devices companies include Abbott Laboratories, Medtronic PLC, Abiomed, Berlin Heart GmbH, BiVACOR Inc, Magenta Medical, CARMAT, CorWave SA, Getinge AB, and others.
Gain a competitive edge in the Cardiac Assist Devices Market by exploring our in-depth analysis @ Cardiac Assist Devices Market Report – https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr
Cardiac Assist Devices Market Overview
The global cardiac assist devices market is transforming the management of advanced heart failure and cardiovascular disease through innovative mechanical circulatory support technologies. Unlike conventional pharmacological management, cardiac assist devices – including ventricular assist devices (VADs), artificial hearts, and intra-aortic balloon pumps – provide direct hemodynamic support, enabling real-time cardiac function augmentation and improved patient survival outcomes.
Growing cardiovascular disease prevalence worldwide, combined with the persistent shortage of donor organs and increasing demand for durable long-term support solutions, continues to fuel market growth. The integration of advanced engineering, AI-enabled pump systems, remote monitoring, and minimally invasive implantation techniques has further expanded the clinical applications of cardiac assist devices across bridge-to-transplant, destination, and bridge-to-candidacy therapy settings.
Factors Driving the Growth of the Cardiac Assist Devices MarketRising Burden of Cardiovascular Diseases
The increasing prevalence of heart failure, ischemic heart disease, and related conditions – driven by aging populations and lifestyle risk factors – is boosting demand for cardiac assist devices as life-saving support systems. According to the British Heart Foundation (2024), approximately 620 million people, or about 1 in 13 individuals globally, live with heart and circulatory diseases, underscoring the scale of unmet need fueling market demand.
Scarcity of Donor Hearts and Long Transplant Waiting Times
Heart transplantation remains the gold standard for end-stage heart failure; however, the severe scarcity of donor organs and prolonged waiting times have intensified demand for cardiac assist devices as interim and permanent alternatives. According to the Health Resources and Services Administration, 3,436 patients were on the waiting list for a heart transplant in the United States in 2024, with 17 people dying daily while awaiting an organ transplant.
Technological Innovation and Miniaturization
Advances in device design – including smaller implantable LVADs, percutaneous pumps, and improved biocompatible materials – have enhanced usability, durability, and patient comfort. For instance, Magenta Medical’s Elevate™ device, the smallest and most powerful percutaneous left ventricular assist device in the world, demonstrated effective temporary mechanical circulatory support during high-risk percutaneous coronary intervention procedures in its US early feasibility study.
Aging Population and Increased Life Expectancy
With global life expectancy climbing, the geriatric segment – particularly prone to cardiovascular complications – is fueling sustained demand for durable cardiac support solutions across both developed and emerging markets.
Shift Toward Minimally Invasive Procedures
Growing adoption of less invasive device implantation techniques, including percutaneous approaches, is reducing patient recovery time, lowering procedural risks, and encouraging broader clinical use of cardiac assist devices across a wider patient population.
Enhanced Reimbursement and Healthcare Infrastructure
Expansion of favorable reimbursement policies and improved healthcare infrastructure – especially in emerging markets – is increasing patient access to cardiac assist devices and supporting long-term market growth.
Strategic Collaborations and R&D Investments
Partnerships between device manufacturers, technology firms, and research institutions are accelerating innovation in areas such as AI-enabled pump systems and enabling faster market penetration across key geographies.
Remote Monitoring and Telemedicine Integration
The integration of telehealth capabilities into cardiac assist devices – enabling remote patient monitoring and early clinical intervention – is making advanced cardiac therapies more accessible, sustainable, and cost-effective for healthcare systems globally.
Cardiac Assist Devices Market Segment Analysis
The Cardiac Assist Devices market is segmented by product, type, therapy, end user, and geography. Among product segments, Left Ventricular Assist Devices (LVADs) are expected to hold a significant share of the market. LVADs serve as a critical bridge to heart transplantation for patients with end-stage heart failure, offering life-saving support by enhancing the heart’s pumping ability and improving blood flow to vital organs.
LVADs are increasingly being adopted as destination therapy for patients who are not candidates for transplantation, further expanding their market reach. Post-implantation, patients typically experience meaningful improvements in health status and are able to resume daily activities. The high demand for LVADs is further supported by a growing patient population with chronic heart conditions, continuous advancements in device technology, and ongoing clinical trials demonstrating their clinical and quality-of-life benefits.
Cardiac Assist Devices Market Regional AnalysisNorth America is Expected to Dominate the Overall Cardiac Assist Devices Market
North America is anticipated to maintain the largest market share throughout the forecast period. This regional leadership is attributed to the increasing prevalence of cardiac disease, persistent shortage of heart donors, robust government initiatives, heightened public awareness programs for cardiovascular conditions, and the active presence of leading cardiac assist devices companies engaged in mergers, acquisitions, product launches, and other strategic market activities.
According to the Centers for Disease Control and Prevention (2024), approximately 4.9% of US adults were diagnosed with coronary heart disease in 2022, and over 795,000 people in the US experience a stroke each year. Additionally, an estimated 12.1 million individuals in the United States are projected to have atrial fibrillation by 2023. This substantial and expanding cardiovascular patient base drives sustained demand for cardiac assist devices across the region.
Asia-Pacific is projected to be the fastest-growing region owing to rising cardiovascular disease rates, expanding healthcare access, growing patient awareness, and favorable pricing models creating untapped growth potential. Meanwhile, Europe, the Middle East, Africa, and South America are also witnessing growing adoption driven by healthcare modernization initiatives and increasing clinical awareness of advanced cardiac support solutions.
Cardiac Assist Devices Key Companies
Cardiac Assist Devices Companies include:
-
Abbott Laboratories
-
Teleflex Incorporated
-
SynCardia Systems, LLC
-
St. Jude Medical Inc.
-
CARMAT
-
CorWave SA
-
Medtronic PLC
-
Terumo Heart, Inc.
-
NovaPump GmbH
-
Getinge AB
-
Balton Ltd.
-
Meril Life Sciences Pvt. Ltd.
-
Thoratec Corporation
-
CardiacAssist, Inc.
-
Berlin Heart GmbH
-
BrioHealth Solutions, Inc.
-
BiVACOR, Inc.
-
Magenta Medical
-
Abiomed
-
SynCardia
-
And Others.
Download the report to understand which factors are driving Cardiac Assist Devices Market Trends – https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr
Latest Highlights from the Cardiac Assist Devices Market
-
In July 2025, CorWave announced the world’s first implantation of its novel Left Ventricular Assist System (LVAS) based on wave membrane technology, marking a significant leap in cardiac assist innovation.
-
In July 2025, Robert Wood Johnson University Hospital received The Joint Commission’s Gold Seal of Approval for its Ventricular Assist Device (VAD) program, reaffirming its clinical excellence in advanced heart failure care.
-
In April 2025, Europe approved a new fully implantable left ventricular assist device (LVAD), a major milestone enhancing long-term, portable support for advanced heart failure patients.
-
In March 2025, Berlin Heart’s EXCOR Apex Cannulae earned FDA approval via a PMA supplement, expanding device design and specifications in mechanical ventricular assist systems.
-
In November 2023, BiVACOR Inc announced that the FDA approved its BiVACOR Total Artificial Heart to begin an investigational device exemption (IDE) for its first-in-human Early Feasibility Study.
-
In October 2022, Abiomed received FDA pre-market approval for its Impella RP Flex with SmartAssist, approved as safe and effective for treating acute right heart failure for up to 14 days.
-
Strategic collaborations between device makers, technology companies, hospitals, and research institutions continue to accelerate commercialization and broader clinical adoption of cardiac assist devices globally.
Discover key developments and opportunities in the Cardiac Assist Devices Market @ Cardiac Assist Devices Market Size – https://www.delveinsight.com/sample-request/cardiac-assist-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr
Cardiac Assist Devices Market Outlook
The cardiac assist devices market is experiencing rapid growth as healthcare systems increasingly embrace advanced mechanical circulatory support solutions for end-stage heart failure and related cardiovascular conditions. Advances in device miniaturization, AI-enabled pump technology, remote monitoring integration, and minimally invasive implantation techniques are significantly improving the clinical utility and patient accessibility of cardiac assist devices.
The market is also benefiting from expanding applications in bridge-to-transplant therapy, destination therapy, and bridge-to-candidacy settings, as well as growing investments, strategic partnerships, and regulatory support accelerating innovation and commercialization. As the global burden of cardiovascular disease continues to rise and donor organ scarcity persists, cardiac assist devices are positioned to become an increasingly indispensable component of advanced heart failure management, enabling improved patient survival, enhanced quality of life, and more personalized therapeutic strategies across North America, Europe, Asia-Pacific, and the Rest of the World.
Scope of the Cardiac Assist Devices Market Report
Study Period: 2022–2032
Forecast Period: 2025–2032
Market Size (2032): USD 6.23 Billion
CAGR (2025–2032): 13.70%
Major Cardiac Assist Devices Companies: Abbott Laboratories, Teleflex Incorporated, SynCardia Systems LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart Inc, NovaPump GmbH, Getinge AB, Balton Ltd, Meril Life Sciences Pvt Ltd, Thoratec Corporation, CardiacAssist Inc, Berlin Heart GmbH, BrioHealth Solutions Inc, BiVACOR Inc, Magenta Medical, Abiomed, SynCardia, and others.
Market Segments Covered: Product, Type, Therapy, End User, and Geography.
Competitive Intelligence Analysis: Market trends, competitive landscape, strategic collaborations, acquisitions, investments, regulatory approvals, and emerging technologies.
Key Focus Areas: Left Ventricular Assist Devices (LVADs), Bridge-To-Transplant Therapy, Destination Therapy, Artificial Hearts, Intra-Aortic Balloon Pumps, Percutaneous Cardiac Support, and AI-Powered Device Innovation.
Table of Contents
-
Cardiac Assist Devices Market Report Introduction
-
Cardiac Assist Devices Market Executive Summary
-
Regulatory Analysis
-
Cardiac Assist Devices Market Key Factors Analysis
-
Cardiac Assist Devices Porter’s Five Forces Analysis
-
Cardiac Assist Devices Market Layout
-
Cardiac Assist Devices Company and Product Profiles
-
KOL Views
-
Project Approach
-
DelveInsight Capabilities
-
About DelveInsight
-
Disclaimer & Contact Us
How DelveInsight’s Cardiac Assist Devices Market Report Helps CXOs and Business Leaders
-
Evaluate the current and future market opportunity across key regions, including the United States, Europe, Asia-Pacific, and Rest of the World, through detailed market forecasts, technology assessments, and growth trend analysis.
-
Benchmark leading cardiac assist device technologies, products, and clinical platforms through comprehensive competitive intelligence, company profiling, product portfolio evaluation, and innovation tracking.
-
Identify potential licensing, acquisition, co-development, and strategic partnership opportunities by monitoring emerging market participants, novel device technologies, and recent industry collaborations, mergers, and investments.
-
Assess the impact of upcoming regulatory approvals, technological advancements, reimbursement developments, and product launches on market share, pricing strategies, adoption rates, and commercial success.
-
Support strategic decision-making with insights into key opinion leader (KOL) perspectives, unmet clinical needs, device adoption trends, therapy utilization patterns, patient stratification approaches, and evolving market dynamics within the Cardiac Assist Devices landscape.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/cardiac-assist-devices-market
